It is not entirely known how Synribo works. One of the ways it is thought to work is by blocking the production of certain proteins that stimulate the development of the abnormal blood cells found in leukemia. Interestingly, Synribo is made from the leaves of an evergreen tree (Cephalotaxus sp., more commonly known as the Cowtail Pine or Japanese Plum Yew).
Synribo is not approved for use in children, as it has not been adequately studied in this age group. Talk with your child's healthcare provider about the particular benefits and risks of using this medicine in children.
Older adults can be treated with Synribo. However, in clinical trials, people who were 65 and older were more likely to experience certain Synribo side effects, such as low levels of white blood cells and platelets. Older adults may need to be monitored more closely.
On occasion, your healthcare provider may recommend this medicine for something other than the condition discussed in this article. This is called an "off-label" use. At this time, there are no well-established off-label uses for Synribo.